<DOC>
	<DOCNO>NCT02932904</DOCNO>
	<brief_summary>The purpose study evaluate effect vortioxetine ( 10 20 mg , daily ) versus paroxetine ( 20 mg , daily ) sexual function healthy participant 5 week double-blind treatment .</brief_summary>
	<brief_title>Effect Vortioxetine , Paroxetine , Placebo Sexual Functioning Healthy Volunteers</brief_title>
	<detailed_description>The drug test study call vortioxetine . This study look effect treatment sexual functioning healthy participant . The study enroll approximately 352 participant . Participants randomly assign ( chance , like flip coin ) one four treatment groups—which remain undisclosed patient study doctor study ( unless urgent medical need ) : - Vortioxetine 10 mg - Vortioxetine 20 mg - Paroxetine 20 mg - Placebo ( dummy inactive pill ) - capsule look like study drug active ingredient All participants ask take one tablet/capsule , daily , orally 5 week . This multicenter trial conduct United States . The overall time participate study approximately 7 week . Participants contact telephone 2 week last dose study drug follow-up assessment .</detailed_description>
	<mesh_term>Vortioxetine</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>1 . Is sexually active steady relationship plan remain relationship duration study . 2 . Has body mass index ( BMI ) 18 35 kg/m^2 , inclusive , Screening Baseline Visits . 3 . If female , regular menstrual cycle . 4 . Has normal sexual functioning Screening Baseline Visits . 5 . If female , take allow hormonal contraceptive stable dose ≥3 month prior Baseline Visit continue stable dose duration study 1 . Has receive vortioxetine and/or paroxetine previous clinical study therapeutic agent . 2 . Is positive hepatitis B surface antigen ( HBsAg ) , antihepatitis C virus ( HCV ) antibody , human immunodeficiency virus ( HIV ) Screening Visit know sexually transmitted disease . 3 . Has glycosylated hemoglobin ( HbA1c ) ≥7 % Screening Visit . 4 . Has clinically significant abnormal electrocardiogram ( ECG ) Screening Visit . 5 . Has know history currently increase intraocular pressure risk acute narrowangle glaucoma . 6 . Has history depression psychiatric illness . 7 . Has significant risk suicide accord investigator 's clinical judgment , make suicide attempt previous 6 month . 8 . Has current sexual dysfunction , history diagnosis treatment sexual dysfunction . 9 . Has surgical medical procedure reproductive/genitourinary organ ( exclude uncomplicated vasectomy tubal ligation ) . 10 . If female , polycystic ovarian syndrome . 11 . Has hypogonadism free testosterone value outside normal range Screening Visit indicative hypogonadism . 12 . Has thyroidstimulating hormone ( TSH ) value outside normal range Screening Visit deem clinically significant investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>